<- Go Home
Talis Biomedical Corporation
Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.
Market Cap
$3.1M
Volume
11.6K
Cash and Equivalents
$59.9M
EBITDA
-$45.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-$20.1M
Profit Margin
4923.77%
52 Week High
$9.60
52 Week Low
$1.37
Dividend
N/A
Price / Book Value
0.06
Price / Earnings
-0.06
Price / Tangible Book Value
0.06
Enterprise Value
-$38.0M
Enterprise Value / EBITDA
1.03
Operating Income
-$46.4M
Return on Equity
70.48%
Return on Assets
-29.59
Cash and Short Term Investments
$59.9M
Debt
$18.8M
Equity
$48.6M
Revenue
$408.0K
Unlevered FCF
-$25.9M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium